UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 525

Sortiert nach

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Nature medicine, 2012-12, Vol.18 (12), p.1835-1840

2012

Link zum Volltext

Verfügbarkeit prüfen

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (8), p.3270-3275

2011

Link zum Volltext

Verfügbarkeit prüfen

The integrated landscape of driver genomic alterations in glioblastoma

Nature genetics, 2013-10, Vol.45 (10), p.1141-1149

2013

Link zum Volltext

Verfügbarkeit prüfen

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Nature communications, 2021-01, Vol.12 (1), p.352-352, Article 352

2021

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Nature communications, 2018-05, Vol.9 (1), p.2087-11, Article 2087

2018

Link zum Volltext

Verfügbarkeit prüfen

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Nature communications, 2021-03, Vol.12 (1), p.1858-1858, Article 1858

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.270-275

2013

Link zum Volltext

Verfügbarkeit prüfen

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Oncotarget, 2014-03, Vol.5 (6), p.1515-1525

2014

Link zum Volltext

Verfügbarkeit prüfen

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Cancer cell, 2016-01, Vol.29 (1), p.49-60

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

Nature communications, 2020-01, Vol.11 (1), p.524-524, Article 524

2020

Link zum Volltext

Verfügbarkeit prüfen

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

PloS one, 2014-04, Vol.9 (4), p.e94281-e94281

2014

Link zum Volltext

Verfügbarkeit prüfen

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

PloS one, 2019-01, Vol.14 (1), p.e0210608

2019

Link zum Volltext

Verfügbarkeit prüfen

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

Archives of pathology & laboratory medicine (1976), 2017-12, Vol.141 (12), p.1697-1704

2017

Link zum Volltext

Verfügbarkeit prüfen

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

PloS one, 2011-02, Vol.6 (2), p.e16812-e16812

2011

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Treatment of Malignant Astrocytoma

Journal of clinical oncology, 2006-03, Vol.24 (8), p.1253-1265

2006

Link zum Volltext

Verfügbarkeit prüfen

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

The Journal of clinical investigation, 2014-10, Vol.124 (10), p.4489-4502

2014

Link zum Volltext

Verfügbarkeit prüfen

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2773-2779

2009

Link zum Volltext

Verfügbarkeit prüfen

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Clinical cancer research, 2006-09, Vol.12 (17), p.5064-5073

2006

Link zum Volltext

Verfügbarkeit prüfen

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Clinical cancer research, 2007-04, Vol.13 (7), p.2158-2167

2007

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

PloS one, 2012-02, Vol.7 (2), p.e31046-e31046

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

SLAS discovery, 2024-03, Vol.29 (2), p.100147-100147, Article 100147

2024

Link zum Volltext

Verfügbarkeit prüfen

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Oncotarget, 2013-11, Vol.4 (11), p.2144-2153

2013

Link zum Volltext

Verfügbarkeit prüfen

Reversing the Warburg Effect as a Treatment for Glioblastoma

The Journal of biological chemistry, 2013-03, Vol.288 (13), p.9153-9164

2013

Link zum Volltext

Verfügbarkeit prüfen

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

The Journal of neuroscience, 2007-10, Vol.27 (42), p.11214-11227

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002203

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 525

Suche als RSS-Feed

Aktive Filter

KollektionAmerican Association for the Advancement of Science

Zeitschrift / SerieCancer Research

ThemaTumors Of The Nervous System. Phacomatoses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(477)

Publikationsform

Artikel
(522)
Buchkapitel
(3)

Sprache

Englisch
(525)
Japanisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

The integrated landscape of driver genomic alterations in glioblastoma

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

Recent Advances in the Treatment of Malignant Astrocytoma

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Reversing the Warburg Effect as a Treatment for Glioblastoma

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Aktive Filter

Suchergebnisse filtern